140 related articles for article (PubMed ID: 20347313)
1. Ubiquitin chain cleavage: CYLD at work.
Massoumi R
Trends Biochem Sci; 2010 Jul; 35(7):392-9. PubMed ID: 20347313
[TBL] [Abstract][Full Text] [Related]
2. CYLD: a deubiquitination enzyme with multiple roles in cancer.
Massoumi R
Future Oncol; 2011 Feb; 7(2):285-97. PubMed ID: 21345146
[TBL] [Abstract][Full Text] [Related]
3. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitination of Lys63-linkage by a CYLD UBP.
Shi Y
Structure; 2008 Mar; 16(3):338-40. PubMed ID: 18334208
[No Abstract] [Full Text] [Related]
5. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
Massoumi R; Paus R
Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.
Stokes A; Wakano C; Koblan-Huberson M; Adra CN; Fleig A; Turner H
Cell Signal; 2006 Oct; 18(10):1584-94. PubMed ID: 16500080
[TBL] [Abstract][Full Text] [Related]
7. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
8. Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B.
Sun L; Gao J; Huo L; Sun X; Shi X; Liu M; Li D; Zhang C; Zhou J
J Pathol; 2010 Aug; 221(4):425-32. PubMed ID: 20593489
[TBL] [Abstract][Full Text] [Related]
9. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
[TBL] [Abstract][Full Text] [Related]
12. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
13. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.
Cui TG; Ichikawa T; Yang M; Dong X; Li J; Cui T
Biochem Biophys Res Commun; 2009 Dec; 390(2):307-12. PubMed ID: 19800320
[TBL] [Abstract][Full Text] [Related]
14. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].
Yang X; An DJ; Gao CC; Qin HY
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):477-480. PubMed ID: 31357769
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.
Xue L; Igaki T; Kuranaga E; Kanda H; Miura M; Xu T
Dev Cell; 2007 Sep; 13(3):446-54. PubMed ID: 17765686
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies.
Newton K; Matsumoto ML; Wertz IE; Kirkpatrick DS; Lill JR; Tan J; Dugger D; Gordon N; Sidhu SS; Fellouse FA; Komuves L; French DM; Ferrando RE; Lam C; Compaan D; Yu C; Bosanac I; Hymowitz SG; Kelley RF; Dixit VM
Cell; 2008 Aug; 134(4):668-78. PubMed ID: 18724939
[TBL] [Abstract][Full Text] [Related]
18. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Komander D; Lord CJ; Scheel H; Swift S; Hofmann K; Ashworth A; Barford D
Mol Cell; 2008 Feb; 29(4):451-64. PubMed ID: 18313383
[TBL] [Abstract][Full Text] [Related]
19. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
20. Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity.
Sato Y; Goto E; Shibata Y; Kubota Y; Yamagata A; Goto-Ito S; Kubota K; Inoue J; Takekawa M; Tokunaga F; Fukai S
Nat Struct Mol Biol; 2015 Mar; 22(3):222-9. PubMed ID: 25686088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
